Uterine Cancer Study Act of 2024

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9782 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 9782

   To direct the Secretary of Health and Human Services to study and 
   report on the relationship between hair straighteners and uterine 
               cancer, particularly among women of color.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 24, 2024

 Ms. Clarke of New York (for herself, Ms. Brown, Mrs. Watson Coleman, 
Ms. Adams, Mrs. Beatty, Ms. Blunt Rochester, Mrs. Cherfilus-McCormick, 
Ms. Crockett, Mr. Davis of North Carolina, Mrs. Fletcher, Mrs. Foushee, 
Ms. Norton, Ms. Kelly of Illinois, Ms. Lee of California, Ms. Lofgren, 
 Mrs. McBath, Ms. McClellan, Mr. Meeks, Ms. Plaskett, Ms. Sewell, Mr. 
Bishop of Georgia, Mr. Carter of Louisiana, Ms. Velazquez, Ms. Williams 
   of Georgia, Ms. Wilson of Florida, Ms. Wasserman Schultz, and Mr. 
    Tonko) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
   To direct the Secretary of Health and Human Services to study and 
   report on the relationship between hair straighteners and uterine 
               cancer, particularly among women of color.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Uterine Cancer Study Act of 2024''.

SEC. 2. STUDY ON RELATIONSHIP BETWEEN HAIR STRAIGHTENERS AND UTERINE 
              CANCER.

    (a) Study.--The Secretary of Health and Human Services, in 
coordination with the Commissioner of Food and Drugs and the Director 
of the National Institutes of Health, shall conduct a study on the 
relationship between hair straighteners and uterine cancer, with a 
focus on the increased incidence of such cancer among women of color. 
Such study shall--
            (1) review significant findings and recommendations from 
        other studies regarding the relationship between hair 
        straighteners and uterine cancer;
            (2) consider impacts on women and other individuals at risk 
        of uterine cancer from all racial and ethnic backgrounds;
            (3) disaggregate the results of the study under this 
        section according to whether the hair straighteners contain 
        dyes or coloring, bleach, highlights, or perms; and
            (4) determine whether the Food and Drug Administration 
        should impose additional testing requirements on the 
        manufacturers of hair straightening products to ensure the 
        safety of such products.
    (b) Methodology.--Not later than 45 days after the date of 
enactment of this Act, the Secretary shall submit to the Committee on 
Energy and Commerce of the House of Representatives and the Committee 
on Health, Education, Labor, and Pensions of the Senate a description 
of the methodology that will be used to conduct the study under this 
section.
    (c) Commencement.--Not later than 180 days after the date of 
enactment of this Act, the Secretary shall commence the study under 
this section.
    (d) Report.--Not later than 2 years after the date of enactment of 
this Act, the Secretary shall complete the study under this section and 
submit to the Committee on Energy and Commerce of the House of 
Representatives and the Committee on Health, Education, Labor, and 
Pensions of the Senate a report on the results of such study.
    (e) Definition.--In this section:
            (1) The term ``hair straightener'' means a chemical hair 
        straightener.
            (2) The term ``Secretary'' means the Secretary of Health 
        and Human Services.
                                 <all>